Blog
)
Science unlocked: publication picks from November 2024
- Biopharma
- RNA
- AMR
- Infectious disease
- Human genomics
- Methylation
December 6 2024
)
Science unlocked: publication picks from May 2025
- Biopharma
- RNA
- AMR
- Methylation
- Virus
- Bacteria
June 11 2025
)
Science unlocked: publication picks from February 2025
- Biopharma
- Cancer research
- Structural variation
- Clinical research
- Adaptive sampling
- Animal
March 5 2025
)
Science unlocked: publication picks from December 2024
- Biopharma
- Clinical research
- Cancer research
- Bioinformatics
- Epigenetics
January 8 2025
)
Nanopore sequencing in biopharma research and development: transforming precision medicine and antibody discovery
- Biopharma
- Clinical research
- Direct analysis
- Methylation
- Epigenetics
November 12 2024
)
London Calling: The future of genomic medicine
- Biopharma
- Clinical
- Clinical research
- Infectious disease
- mRNA
- Long-read
May 28 2024
)
Oxford Nanopore’s roadmap to proteomics
- Biopharma
- Protein
- Direct analysis
- Human genomics
- London Calling
- Multiomics
May 21 2025
)
10 ways the Nanopore Community redefined genomics in 2024
- Biopharma
- Adaptive sampling
- Animal
- Bacteria
- Basecalling
- Cancer research
December 20 2024
)
Deep insights into the immune response with multiomic nanopore sequencing
- Biopharma
- Cancer research
- DNA
- Epigenetics
- Human genomics
- Infectious disease
September 26 2024
)
Celebrating a decade of innovation: reflecting on London Calling and the future of nanopore sequencing
- Biopharma
- MinION
- Methylation
- London Calling
- Clinical research
- DNA
May 22 2024
)
Advancing Biopharma quality control: Oxford Nanopore Technologies at NCM Boston 2024
- Biopharma
- Supply chain monitoring
- Food safety
- Long-read
- Short-read
- Targeted
September 18 2024
